Comment on Sung et al. Body Fat Reduction Effect of Bifidobacterium breve B-3: A Randomized, Double-Blind, Placebo Comparative Clinical Trial. Nutrients 2023, 15 , 28.

Published in: Nutrients (2023)

I read with interest the paper by Sung et al. entitled "Body Fat Reduction Effect of Bifidobacterium breve B-3: A Randomized, Double-Blind, Placebo Comparative Clinical Trial" where a reduction in body fat mass after Bifidobacterium breve B-3 (BB-3) ingestion for 12 weeks was reported [...].

Keyphrases

double blind
clinical trial
placebo controlled
phase iii
phase ii
study protocol
open label
heavy metals
growth factor
randomized controlled trial
single molecule
risk assessment
gestational age